KalVista Pharmaceuticals, Inc.
KALVDelisted Jun 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348911
KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding KalVista Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 110 | 1 | 105 | −4 |
| Shares | 24.3M | 22.5K | 23.4M | −916.9K (−3.8%) |
| Value | $582.7M | $540.0K | $408.2M | −$173.9M (−29.9%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Frazier Management LLC | 156,807 | $2.74M | 0.22% |
| Monashee Investment Management LLC | 125,000 | $2.18M | 0.40% |
| Millennium Management LLC | 36,715 | $641.0K | 0.00% |
| Jump Financial, LLC | 30,779 | $537.0K | 0.04% |
| First Trust Advisors LP | 29,530 | $515.0K | 0.00% |
| HRT Financial LP | 27,296 | $476.0K | 0.00% |
| Renaissance Technologies LLC | 23,528 | $411.0K | 0.00% |
| ExodusPoint Capital Management, LP | 19,173 | $335.0K | 0.01% |
| Trexquant Investment LP | 19,138 | $334.0K | 0.03% |
| Tibra Equities Europe Ltd | 14,300 | $250.0K | 0.38% |
| Alpine Global Management, LLC | 12,754 | $223.0K | 0.05% |
| Connor, Clark & Lunn Investment Management Ltd. | 11,887 | $207.0K | 0.00% |
| Pinz Capital Management, LP | 6,000 | $105.0K | 0.05% |
| Lindbrook Capital, LLC | 1,000 | $17.0K | 0.00% |
| Cutler Group LP | 100 | $1.00K | 0.00% |
| Harbour Investments, Inc. | 1 | $0 | 0.00% |
Sold out (20)
Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Polar Capital Holdings Plc | 617,180 | $14.8M |
| Affinity Asset Advisors, LLC | 50,000 | $1.20M |
| Ensign Peak Advisors, Inc | 47,116 | $1.13M |
| Marshall Wace North America L.P. | 22,136 | $530.0K |
| Marshall Wace, LLP | 16,996 | $407.0K |
| Silverarc Capital Management, LLC | 14,882 | $357.0K |
| Parametric Portfolio Associates LLC | 13,918 | $333.0K |
| STRS Ohio | 13,000 | $311.0K |
| Legato Capital Management LLC | 12,903 | $309.0K |
| State Board of Administration of Florida Retirement System | 9,695 | $232.0K |
| ProShare Advisors LLC | 9,546 | $229.0K |
| Squarepoint Ops LLC | 8,919 | $214.0K |
| Acadian Asset Management LLC | 6,002 | $144.0K |
| Nisa Investment Advisors, LLC | 2,400 | $58.0K |
| Panagora Asset Management Inc | 278 | $7.00K |
| US Bancorp | 113 | $3.00K |
| TCI Wealth Advisors, Inc. | 99 | $2.00K |
| The PNC Financial Services Group, Inc. | 59 | $1.00K |
| Federated Hermes, Inc. | 39 | $1.00K |
| Captrust Financial Advisors | 41 | $1.00K |
Not filed for Q3 2021 yet (1)
Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 22,532 | $540.0K |